Hyperparathyroidism in high-risk surgical patients: Evaluation with double-phase technetium-99m sestamibi imaging

Radiology

Volumn 197, Issue 3, 1995, Pages 627-633

  Lee, Vivian S ^a   Wilkinson Jr , Robert H ^a   Leight Jr , George S ^a   Coogan, Alice C ^a   Coleman, R Edward ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Parathyroid, hyperparathyroidism; Parathyroid, neoplasms; Parathyroid, radionuclide studies

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORGAN WEIGHT; PARATHYROID SCINTISCANNING; PRIORITY JOURNAL; SURGICAL RISK; VASCULARIZATION;

EID: 0028867440     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.197.3.7480730     Document Type: Article

References (42)

1. Boonstra CE, Jackson CE. Serum calcium survey for hyperparathyroidism: results in 50,000 clinic patients. Am J Clin Path 1971; 55:523-526.
2. Heath H III, Hodgson SF, Kennedy MA. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980; 302:189-193.
3. Preisman RA, Mehnert JH. A plethora of primary hyperparathyroidism. Arch Surg 1971; 103:12-13.
4. Consensus Development Conference Panel. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Int Med 1991; 114:593-597.
5. Ferlin C, Borsato N, Camerani M, Conte N, Zotti D. New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan. J Nucl Med 1983; 24:438-441.
6. Young AE, Gaunt JI, Croft DN, Collins REC, Wells CP, Coakley AJ. Location of parathyroid adenomas by thallium-201 and tochnetium-99m subtraction scanning. Br Med J 1983; 286:1384-1386.
7. Price DC. Parathyroid imaging: effectiveness of different methodologies. In: Gooding CA, ed. Diagnostic radiology 1990. San Francisco, Calif: University of California, San Francisco, Radiology Research and Education Foundation, 1990; 489-502.
8. m sestamibi: a new agent for parathyroid imaging. Nucl Med Commun 1989; 10:791-794.
9. O'Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with technetium-99m sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992; 33:313-318.
10. Wei JP, Burke GJ, Mansberger AR Jr. Prospective evaluation of the efficacy of technetium 99m sestamibi and iodine 123 radionuclide imaging of abnormal parathyroid glands. Surgery 1992; 112:1111-1117.
11. 123I subtraction scanning. J Clin Endocrinol Metab 1993; 78:77-82.
12. Casas AT, Burke GJ, Sathyanarayana, Mansberger AR Jr, Wei JP. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism. Am J Surg 1993; 166:369-373.
13. Weber CJ, Vansant J, Alazraki N, et al. Value of lechnetium 99m sestamibi iodine 123 imaging in reoperative parathyroid surgery. Surgery 1993; 114:1011-1018.
14. Geatti O, Shapiro B, Orsolon PG, et al. Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutyl-isonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography. Eur J Nucl Med 1994; 21:17-22.
15. Wei JP, Burke GJ, Mansberger AR Jr. Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans. Ann Surg 1994; 219:568-573.
16. Khan A, Samtani S, Varma VM, Frost A, Cohen J. Preoperative parathyroid localization: prospective evaluation of technetium 99m sestamibi. Otolaryngol Head Neck Surg 1994; 111: 467-472.
17. Hindie E, Melliere D, Simon D, Perlemuter L, Galle P. Primary hyperparathyroidism: is technetium 99m-sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab 1995; 80:302-307.
18. Thompson GB, Mullan BP, Grant CS, et al. Parathyroid imaging with technetium-99m-sestamibi: an initial institutional experience. Surgery 1994; 116:966-973.
19. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992; 33:1801-1807.
20. Irvin GL III, Prudhomme DL, Deriso GT, Sfakianakis G, Chandarlapaty SKC. A new approach to parathyroidectomy. Ann Surg 1994; 219:574-581.
21. Wang CA. Parathyroid re-exploration: a clinical and pathological study of 112 cases. Ann Surg 1977; 186:140-145.
22. Edis AJ, Sheedy PF II, Beahrs OH, van Heerden JA. Results of reoperation for hyperparathyroidism, with evaluation of preoperative localization studies. Surgery 1978; 84:384-391.
23. Brennan MF, Marx SJ, Doppman J, et al. Results of reoperation for persistent and recurrent hyperparathyroidism. Ann Surg 1981; 194:671-676.
24. Cheung PSY, Borgstrom A, Thompson NW. Strategy in reoperative surgery for hyperparathyroidism. Arch Surg 1989; 124:676-680.
25. Silver CE, Velez FJ. Parathyroid re-exploration. Am J Surg 1992; 164:606-609.
26. Patow CA, Norton JA, Brennan MF. Vocal cord paralysis and reoperative parathyroidectomy: a prospective study. Ann Surg 1986; 203: 282-285.
27. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York, NY: Wiley, 1981.
28. Rossitch JC, Cowan RJ, Ellis MB, Griffith RF. Tc-99m sestamibi for detection of parathyroid adenoma: comparison of single and dual tracer imaging. Clin Nucl Med 1995; 20:220-221.
29. Bénard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med 1995; 36:241-243.
30. Staudenherz A, Telfeyan D, Steiner E, Niederle B, Leitha T, Kletter K. Scintigraphic pitfalls in giant parathyroid glands. J Nucl Med 1995; 36:467-469.
31. Billotey C, Aurengo A, Najean Y, et al. Identifying abnormal parathyroid glands in the thyroid uptake area using technctium-99m-sestamibi and factor analysis of dynamic structures. J Nucl Mod 1994; 35:1631-1636.
32. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)-technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
33. Sandrock D, Merino MJ, Norton JA, Neumann RD. Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy. J Nucl Med 1993; 34:24-29.
34. Foss JN, Sfakianakis GN, Irvin G. Parathyroid scintigraphy: increased sensitivity of Tc-99m sestamibi SPECT protocol in hyperparathyroidism (abstr). Radiology 1994; 193(P):246.
35. Neumann DR, Esselstyn CB Jr, Go RT, et al. Comparison of double-phase Tc-99m sestamibi SPECTT with simultaneous I-123 Tc-99m sestamibi subtraction SPECT for preoperative localization of hyperparathyroid tissue (abstr). Radiology 1994; 193(P):246.
36. Chan TYK, Serpell JW, Chan O, Gaunt JI, Young AE, Nunan TO. Misinterpretation of the upper parathyroid adenoma on thallium-201/technetium-99m subtraction scintigraphy. Br J Rad 1991; 54:1-4.
37. Chen CC, Premkumar A, Hill SC, Skarulis MC, Spiegel AM. Tc-99m sestamibi imaging of a hyperfunctioning parathyroid autograft with doppler ultrasound and MRI correlation. Clin Nucl Med 1995; 20:222-225.
38. O'Driscoll CM, Baker F, Casey MJ, Duffy GJ. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report. J Nucl Med 1991; 32:2281-2283.
39. Bruining HA, Birkenhäger JC, Ong GL, Lamberts SWJ. Causes of failure in operations for hyperparathyroidism. Surgery 1987; 101:562-565.
40. Levin KE, Clark OH. The reasons for failure in parathyroid operations. Arch Surg 1989; 124:911-915.
41. Doherty GM, Weber B, Norton JA. Cost of unsuccessful surgery for primary hyperparathyroidism. Surgery 1994; 116:954-958.
42. Casas AT, Burke GJ, Mansberger AR Jr, Wei JP. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Am Surg 1994; 60:12-16.